CAT
Caterpillar Inc.
CAT has the edge over RGP overall, supported by stronger modeled upside and stronger fundamentals.
RGP
Resources Connection, Inc.
RGP offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
RGP Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Strong |
RGP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
RGP PE Valuation
RGP has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over RGP on the outlook, with more favorable earnings and revenue expectations.
RGP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect RGP's losses to grow, with revenue declining. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over RGP on earnings quality, reporting a profit while its opponent remains loss making.
RGP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.37 | +$4.33 |
| Q2 2026 | -$1.21 | +$4.59 |
| Q1 2026 | -$2.94 | +$0.34 |
| Q4 2025 | -$4.00 | -$2.14 |
| Q3 2025 | -$5.70 | -1683% |
| Q2 2025 | -$5.80 | -1035% |
| Q1 2025 | -$3.28 | -605% |
| Q4 2024 | -$1.86 | -338% |
RGP is still losing money, but far less than before: $1.37 per share over the past year, against $5.80 at its worst in mid-2025.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over RGP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over RGP on profitability, with a higher operating margin.
RGP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $98.1M | -18% |
| Q2 2026 | $106.1M | -24% |
| Q1 2026 | $107.9M | -17% |
| Q4 2025 | $117.7M | -19% |
| Q3 2025 | $120.2M | -12% |
| Q2 2025 | $139.3M | -6% |
| Q1 2025 | $129.4M | -14% |
| Q4 2024 | $145.6M | -11% |
RGP's revenue has slid since its 2022 peak: $98M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.5% | -5.8 points |
| Q2 2026 | -15% | +32 points |
| Q1 2026 | -7.7% | +31 points |
| Q4 2025 | -10% | +42 points |
| Q3 2025 | -1.6% | +1.9 points |
| Q2 2025 | -47% | -55 points |
| Q1 2025 | -38% | -41 points |
| Q4 2024 | -53% | -58 points |
RGP's operating margin was −7.5% last quarter, down 5.8 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over RGP on cash generation, producing positive trailing cash flow while its opponent burns cash.
RGP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$19.2M | -$11.2M |
| Q2 2026 | $1.8M | -89% |
| Q1 2026 | -$8.8M | -3808% |
| Q4 2025 | $15.6M | +25425% |
| Q3 2025 | -$8M | -$7.4M |
| Q2 2025 | $16.5M | +441% |
| Q1 2025 | $238K | -99% |
| Q4 2024 | $61K | -50% |
RGP's free cash flow has turned negative after years in the green: −$11M over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over RGP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
RGP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3% | +1M shares |
| 1 year | +4.5% | +1.5M shares |
| 3 years | +1.6% | +544K shares |
| 5 years | +3.7% | +1.2M shares |
| Available history | +6.8% | +2.2M shares |
RGP has 35M diluted shares, up 4.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $15,000 |
| Q1 2025 | $3M |
| Q4 2024 | $5M |
| Q3 2024 | $5M |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
RGP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -3.3x | Net Cash |
| Q2 2024 | -2.9x | Net Cash |
| Q1 2024 | -2.6x | Net Cash |
| Q4 2023 | -2.1x | Net Cash |
| Q3 2023 | -1.8x | Net Cash |
| Q4 2022 | -0.7x | Net Cash |
| Q3 2022 | -0.5x | Net Cash |
| Q2 2022 | -0.6x | Net Cash |
RGP has more cash than debt.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RGP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.8 | Neutral |
| Stochastic | 15.2 | Oversold |
RGP's weekly RSI is 31 (neutral) and its Stochastic is 15 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
RGP PE vs Industrials Sector
| Metric | RGP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
RGP has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over RGP on trend strength, trading above more of its moving averages.
RGP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.97 | 9.4% below |
| 20 week MA | $3.74 | 28% below |
| 50 week MA | $4.08 | 34% below |
| 100 week MA | $5.00 | 46% below |
| 200 week MA | $9.14 | 71% below |
RGP is in a downtrend: it's below all five of its weekly moving averages, and 71% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over RGP on returns for 2026, with the stronger performance.
RGP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.3 | $12.4 | -24% |
| 2021 | $12.4 | $17.8 | +43% |
| 2022 | $17.8 | $18.5 | +4.2% |
| 2023 | $18.5 | $14.2 | -23% |
| 2024 | $14.2 | $8.41 | -41% |
| 2025 | $8.41 | $5.26 | -37% |
| 2026 YTD | $5.26 | $2.69 | -49% |
RGP has finished three years in a row lower, and it's down 49% so far in 2026.